AN OLD ADAGE MANAGEMENT PERSPECTIVE FOR DANDRUFF

Dandruff is a well-known and global consumer problem, characterized by flaking and scaling of the scalp, with itching and irritation. Although it is not a life-threatening disease, but it is directly related to individual self-esteem, confidence, and beauty. Approximately half of the population is suffering from dandruff and expending around billions of dollars, including hospital services and counter products. Despite its frequency, much controversy remains regarding the pathogenesis of dandruff. Many studies postulated that dandruff is caused by various microbial and non–microbial factors and interaction between them, such as Malassezia fungi, sebum secretion, and individual susceptibility. But some recent researches also claimed that dandruff is not only produced by fungi but there are some bacteria that also play a significant role in accelerating dandruff.  The present treatment includes antifungal agents, no doubt, they have significant results but with lots of side effects and limitations. So, there’s a need to formulate a cost-effective product that possesses anti-dandruff activity, and Zulamla (Hamdard Laboratory Patent Product) is used and is in the public domain from the last 35 years with no side effects. In this paper, dandruff etiology, pathogenesis, and pharmacological studies on Zulamla ingredients are discussed.